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Abstract
Introduction The benefits of β-adrenergic stimulation have been
described in acute lung injury (ALI), but there is still no evidence
of its anti-inflammatory effect in these patients. Biomarkers in
exhaled breath condensate (EBC) were used to study the
effects of salbutamol on lung inflammation in mechanically
ventilated patients with ALI.
Methods EBC was collected before and 30 minutes after
administration of inhaled salbutamol (800 μg). The following
parameters were measured in the samples: volume obtained,
conductivity, pH after helium deaeration, and concentration of
nitrites, nitrates and 8-isoprostane. The leukotriene B4
concentration was measured after sample lyophilization and
reconstitution. Results are expressed as the median
(interquartile range).
Results EBC was obtained from six ALI patients, with a median
age of 56 (46 to 76) years. At the time of EBC collection, the
Lung Injury Score was 3 (2.3 to 3.1) and the PaO2/FIO2 ratio
was 133 (96 to 211) mmHg. A significant increase in deaerated
EBC pH was observed after salbutamol administration (7.66
(7.58 to 7.75) versus 7.83 (7.67 to 7.91), P = 0.028). Trends
toward decreased nitrosative species (18.81 (13.33 to 49.44)
μM versus 21.21 (8.07 to 29.83) μM,  P  = 0.173) and
decreased 8-isoprostane concentration (11.64 (7.17 to 17.13)
pg/ml versus 6.55 (4.03 to 9.99) pg/ml, P  = 0.068) were
detected. No changes in leukotriene B4 concentration were
found (1.58 (0.47 to 3.57) pg/ml versus 2.06 (1.01 to 3.01) pg/
ml, P = 0.753).
Conclusion EBC analysis is a noninvasive technique that can
be used to monitor ventilated patients. In EBC from a small
cohort of patients with ALI, inhaled salbutamol significantly
decreased airspace acidosis, a marker of inflammation, and was
associated with a trend toward decreased markers of nitrosative
and oxidative stress.
Introduction
Collection of exhaled breath condensate (EBC) is a novel non-
invasive means of obtaining lower respiratory tract samples
that can be repeated several times with short intervals
between sampling [1]. The collection devices can be used in
patients breathing spontaneously as well as in mechanically
ventilated patients. The technique is based on the hypothesis
that particles exhaled in breath reflect the composition of the
alveolar lining fluid. Inflammatory markers and several mole-
cules can be detected in EBC. The concentration of these
mediators is influenced by lung diseases and may be modu-
lated by therapeutic interventions; hence, EBC analysis could
be a useful, noninvasive technique for monitoring the evolution
of lung diseases.
Several studies have reported mediator changes in EBC sam-
ples from acute respiratory distress syndrome (ARDS)
patients, such as an increased hydrogen peroxide concentra-
ALI = acute lung injury; ARDS = acute respiratory distress syndrome; EBC = exhaled breath condensate; IL = interleukin; 8-isoPGF2α = 8-isopros-
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tion [2] and an increased 8-isoprostane (8-isoPGF2α) concen-
tration in patients with, or at risk for, ARDS as compared with
normal control subjects [3]. A correlation between the EBC
nitrite concentration and the tidal volume has been found in
acute lung injury (ALI) patients, possibly reflecting ventilator-
associated lung injury [4]. The EBC pH has been related to the
extent of lung injury, and a good correlation with EBC IL-6 and
IL-8 concentrations has been observed [5]. In addition, ALI
and ARDS patients show higher EBC cytokine concentrations
than healthy volunteers [6].
The potential benefits of β-adrenergic stimulation in ALI
include epithelial protection, decreased neutrophil chemotaxis
and activation, lower proinflammatory cytokine production,
increased surfactant secretion, improved respiratory mechan-
ics, and increased alveolar fluid clearance [7-9]. No studies
have been conducted, however, to determine the possible
anti-inflammatory effect of β-adrenergic drugs in ALI patients
by measuring biomarkers in EBC or plasma, even though stud-
ies in healthy volunteers have suggested that salbutamol may
be effective for this purpose [10,11].
The aim of the present study was to use EBC biomarkers to
investigate whether salbutamol has anti-inflammatory effects
on the lungs of mechanically ventilated patients with ALI.
Materials and methods
Study population
Mechanically ventilated adult patients who met the criteria for
ALI according to the American–European Consensus Confer-
ence definition [12] were eligible for participation in the study.
All patients were ventilated according to the ARDS Network
low tidal volume (ARMA)study protocol [13]. The exclusion cri-
teria were age < 18 years, chronic obstructive pulmonary dis-
ease with chronic β-adrenergic treatment, β-adrenergic
agents taken within 12 hours before enrollment, unstable
asthma, coronary artery disease with a contraindication for β-
agonist administration, surgical procedure required within 24
hours before enrollment, immunosuppressive therapy (ster-
oids > 20 mg/day, chemotherapy, or other immunosuppres-
sive agents within 2 weeks), administration of nonsteroidal
anti-inflammatory drugs, pregnancy, participation in other
interventional trials 30 days prior to enrollment, or allergy to
salbutamol.
The study was approved by the local Ethics Committee and
informed consent was obtained from the patients' family
before inclusion.
Clinical data
Ventilatory parameters, pulmonary gas exchange, the Lung
Injury Score [14], and the Sequential Organ Failure Assess-
ment score [15] were recorded before starting EBC collec-
tion. The presence of infection was investigated before
starting treatment. Electrocardiographic, hemodynamic, and
respiratory parameters were monitored during EBC collection
and salbutamol administration.
Exhaled breath condensate samples
Samples were collected before and 30 minutes after adminis-
tration of inhaled salbutamol (800 μg: measured pH, 7.0) by
metered-dose inhaler (Salbutamol Aldo-Unión EFG, Esplu-
gues de Llobregat, Spain). EBC was collected using a com-
mercially available condenser (EcoScreen; Jaeger, Würzburg,
Germany), fitted with an adapter for mechanically ventilated
patients (VentAdapter; FILT Lung and Chest Diagnostic
GmbH, Berlin, Germany). The heat and moisture exchanger
was removed 1 minute before starting EBC collection. The
EBC condenser cooled exhaled breath at -20°C. The collector
temperature was measured at the beginning of collection. The
EBC (1 to 2 ml) was collected in 25 to 45 minutes, depending
on the patient's volume per minute. Samples were transferred
immediately to the laboratory for processing.
Each EBC sample was divided into 500 μl aliquots in two to
four polypropylene tubes (Biosigma, Venice, Italy). The aliq-
uots, used for the measurement of nitrites, nitrates, 8-
isoPGF2α and leukotriene B4 (LTB4), were immediately stored
at -70°C, and were analyzed within 1 month after collection.
The other aliquots were used to measure the conductivity and
pH before and after deaeration.
pH and conductivity measurement
The pH was measured in one of the aliquots immediately after
deaeration with helium (350 ml/min for 10 minutes), using a
model GLP 21 calibrated pH meter (Crison Instruments SA,
Barcelona, Spain) with an accuracy of ± 0.01 pH. Conductiv-
ity was measured immediately after collection using a model
COND 510 conductivity meter (XS Instruments; OptoLab,
Milan, Italy) with an accuracy of ± 1%.
Exhaled breath condensate nitrite/nitrate, 8-isoprostane 
and leukotriene B4 concentrations
The nitrate/nitrite concentration was determined by a colori-
metric assay based on the Griess reaction in which sample
duplicates were reacted with Griess reagent (Cayman Chem-
ical, Ann Arbor, MI, USA) and were measured at 540 nm
absorbance with a microplate reader. The assay sensitivity
was 1 μM for nitrite and 2.5 μM for nitrate.
The EBC 8-isoPGF2α concentration was determined by a
competitive enzyme immunoassay using a commercially avail-
able kit (Cayman Chemical). The assay sensitivity was 4 pg/ml.
The LTB4 concentration in EBC samples was determined by a
LTB4 EIA kit (Cayman Chemical) after sample lyophilization
and reconstitution. The assay sensitivity was 13 pg/ml.Available online http://ccforum.com/content/12/3/R72
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Statistical analysis
Descriptive statistics are expressed as the median (interquar-
tile range). Differences between groups were analyzed by the
Wilcoxon test. Spearman's rank correlation coefficient was
applied to determine correlations between the various param-
eters studied. Significance was set at P < 0.05 (two-sided).
SPSS 13.0 for Windows (SPSS, Inc., Chicago, IL, USA) was
used for the statistical analyses.
Results
General characteristics of the study population
Six patients (four males, two females) aged 56 (46 to 76)
years were studied; none were current smokers. The origin of
ALI was intrapulmonary in five patients. The etiologies included
pneumonia (four patients), smoke inhalation (one patient), and
extrapulmonary sepsis (one patient). Before EBC collection,
patients had been mechanically ventilated for 55 (37 to 76)
hours, and evolution of lung injury was 58 (32 to 79) hours.
At the time of EBC collection, the patients' Lung Injury Score
was 3 (2.3 to 3.1) and the PaO2/FIO2 ratio was 133 (96 to
211) mmHg. The Sequential Organ Failure Assessment score
was 9 (5.8 to 12). No significant changes were observed in
the plateau pressure (27 (24 to 30) cmH2O versus 26 (21 to
29) cmH2O, P = 0.416) or in the intrinsic positive end-expira-
tory pressure (0.5 (0 to 2.5) cmH2O versus0.25 (0 to 0.9)
cmH2O, P = 0.18) following salbutamol administration.
Pulmonary gas exchange values before and after salbutamol
inhalation are summarized in Table 1. There were no adverse
events related to EBC collection or salbutamol inhalation.
Exhaled breath condensate measurements
The main results of EBC measurement are presented in Table
2. Before salbutamol administration, there was a significant
correlation between postdeaeration pH and nitrite levels (r = -
0.899,  P  = 0.015). A positive correlation was also found
between nitrosative species and LTB4 (r = 0.943, P = 0.005),
and between nitrosative species and 8-isoPGF2α (r = 0.9, P =
0.037). The tidal volume, the PaO2/FIO2 ratio, and the Lung
Injury Score showed no correlations with EBC pH or biomark-
ers.
Deaerated pH values were higher after salbutamol inhalation
than before (P = 0.028). Total nitrates and LTB4 were detect-
able in EBC samples from all patients, whereas nitrites and 8-
isoPGF2α were detectable in five patients. A tendency to
decreased nitrosative species and decreased 8-isoPGF2α
concentrations was observed after salbutamol inhalation (P =
0.173 and P = 0.068).
Discussion
In the present small study, we report the apparent anti-inflam-
matory effects of an inhaled β-adrenergic agent in ALI patients
on biomarkers in EBC. A significant increase was observed in
the deaerated EBC pH after salbutamol inhalation, as well as
a trend to decreased total nitrate and 8-isoPGF2α concentra-
tions.
The pH of the airway lining fluid is the result of a balance
between different buffer systems and the production and
release of acids and bases in the airways [1]. In a healthy air-
way, several factors favor acidification of the airway lining fluid,
such as secretion by alveolar type 2 cells and macrophages,
necrosis of macrophages and the alveolar carbon dioxide par-
tial pressure (pCO2). The pH becomes more alkaline in the
proximal airway owing to airway epithelial cell enzyme systems,
ion channel activity and buffering proteins [16]. The normal
range of EBC pH for healthy subjects is 7.4 to 8.8 [1].
Few studies have reported EBC pH values for mechanically
ventilated patients. In otherwise healthy patients undergoing
lung resection for cancer, the mean EBC pH obtained using
RTubes™ was 7.8 [17]. Another study of patients undergoing
cardiothoracic surgery that used the same EBC collection
device reported pH values between 5 and 7 [18]. Finally, using
Table 1
Pulmonary gas exchange values before and after salbutamol administration
Salbutamol P value
Before administration After administration
PH 7.45 (7.39 to 7.51) 7.43 (7.37 to 7.46) 0.080
PaO2/FIO2 ratio (mmHg) 133 (96 to 211) 140 (102 to 154) 0.600
Partial pressure of arterial carbon dioxide (PaCO2) (mmHg) 41 (37 to 48) 43 (39 to 50) 0.072
Bicarbonate (HCO3
-) (mmol/l) 26.5 (23.5 to 32.7) 26 (24 to 32.3) 0.680
Base excess (BE) (mmol/l) 2.4 (-1.4 to 9.1) 2.2 (-0.6 to 8.7) 0.916
Arterial oximetry (SaO2) (%) 97 (96 to 98) 97 (96 to 98) 1.000
Results expressed as the median (interquartile range).Critical Care    Vol 12 No 3    Roca et al.
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the EcoScreen in mechanically ventilated patients, a mean
deaerated EBC pH value of 5.98 was reported [5]. In that
study, however, the pH measurements were performed at
10°C – in contrast to our study, where the pH was measured
when the sample reached room temperature. The condensing
equipment and the condensing and measuring temperatures
used may all affect the EBC pH [19], making comparison of
reported results between studies difficult.
Three essential mechanisms in ALI patients may lead to EBC
acidification [5]. Firstly, lactate production is increased in
hypoxia due to continuing glucose utilization. Secondly, there
is a reduced local buffer capacity secondary to inhibition of
glutaminase activity [20]. Finally, neutrophilic inflammation and
oxidative stress in the airspace associated with multiple lung
diseases [21] has been associated with acidification of EBC
that was reversible with anti-inflammatory therapy.
EBC acidity is an important marker of lung inflammation, and
the higher EBC pH values detected after a single dose of salb-
utamol in our study could be related to an anti-inflammatory
effect of β-adrenergic stimulation in ALI patients. No signifi-
cant changes in the partial pressure of arterial carbon dioxide
(PaCO2) after salbutamol inhalation were observed, which
means that changes observed in the pH were not caused by
changes in alveolar ventilation. In a recent study, EBC pH val-
ues were continuously monitored in mechanically ventilated
patients, and EBC acidification was observed even before the
clinical alteration appeared [22]. This phenomenon has also
been observed in studies on chronic obstructive pulmonary
disease [22] and asthma exacerbations [20,21], bronchiesta-
sis [21], cystic fibrosis [23], and other studies on ALI [5,18].
To date there are no reports investigating the possible anti-
inflammatory effect of β-adrenergic drugs in ALI patients. The
anti-inflammatory effect of this agent has been demonstrated,
however, in healthy volunteers undergoing prior lipopolysac-
charide inhalation, which generates a neutrophil influx and
degranulation into the lungs. This effect was strongly reduced
by salmeterol inhalation [10]. Likewise, salbutamol inhibits
platelet-activating factor-induced pulmonary neutrophil
sequestration [11].
Experimental data have shown that β-adrenergic stimulation
can significantly decrease proinflammatory cytokine expres-
sion, chemokine mRNA induction, and the resultant neutrophil
lung infiltrate in an animal model of endotoxin-induced ALI
[24]. More recently, Perkins and colleagues [25] demon-
strated that salbutamol can stimulate epithelial repair, and the
results of another retrospective study suggest that high doses
of salbutamol are associated with shorter duration and less
severe acute lung injury [26]. In addition to this potential anti-
inflammatory effect, there may be beneficial mechanical
effects and improved reabsorption of pulmonary edema. Effec-
tively, it has been shown that airway resistance and peak and
plateau pressures decrease, and that dynamic compliance
improves with salbutamol administration [27-29]. Moreover,
some studies have demonstrated that β-adrenergic stimulation
increases alveolar fluid clearance [9,30,31], by stimulating the
apical amiloride-sensitive sodium channel and the baseline
Na+/K+-ATPase alveolo-capillary channel, which allows pas-
sage of water from the alveoli to the interstitium [32]. Never-
theless, a direct effect of salbutamol inhalation on EBC pH
cannot be ruled out, even though there is no published evi-
dence indicating this fact and the measured salbutamol pH
was neutral.
A trend towards decreased nitrosative species and 8-
isoPGF2α was observed after a single dose of salbutamol. Few
studies to date have used EBC in mechanically ventilated
patients, particularly in ALI patients [3-6,18,22]. Several
inflammatory mediators are present in EBC samples, such as
interleukins [5,6], leukotrienes [18], reactive oxygen [3] and
nitrogen species [4]. Pulmonary nitric oxide production has
been shown to be stimulated by mechanical forces [33].
Release of pulmonary nitric oxide species may reflect alveolar
distension and inflammation. In fact, EBC nitrite has been
closely correlated to tidal volume, and the EBC nitrite and tidal
volume ratio has been strongly correlated to the extent of lung
injury, using the oxygenation criteria of the consensus defini-
tion or the Lung Injury Score [4]. The nitrosative species
decrease observed in the present study could therefore be
related to some improvement in mechanical stress in these
patients, even though no significant changes in plateau pres-
Table 2
Exhaled breath condensate biomarkers before and after salbutamol administration
Salbutamol P value
Before administration After administration
pH after deaeration 7.66 (7.58 to 7.75) 7.83 (7.67 to 7.91) 0.028
Conductivity (μS) 74 (25.4 to 166) 64 (41.1 to 293.5) 0.465
Leukotriene B4 (pg/ml) 1.58 (0.47 to 3.57) 2.06 (1.01 to 3.01) 0.753
Nitrite (μM) + nitrate (μM) 18.81 (13.33 to 49.44) 21.21 (8.07 to 29.83) 0.173
8-isoprostane (pg/ml) 11.64 (7.17 to 17.13) 6.55 (4.03 to 9.99) 0.068
Results expressed as the median (interquartile range).Available online http://ccforum.com/content/12/3/R72
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sure or intrinsic positive end-expiratory pressure were
observed, probably because their values before salbutamol
inhalation were normal. 8-isoPGF2α is a marker of oxidative
stress [34] in patients with asthma, interstitial lung disease,
chronic obstructive pulmonary disease, cystic fibrosis and ALI
[1,3]. Our results suggest that salbutamol inhalation may play
a role in preventing the lipid peroxidation that occurs in ALI and
ARDS patients, although further study is needed to confirm
this hypothesis.
No changes were seen in the EBC LTB4 concentration after
salbutamol administration, a finding that may have been
affected by the small sample size and by the fact that only sin-
gle-dose administration was tested.
The present study is preliminary and has some limitations
related to the EBC technique and to the small size of the
patient cohort. The samples obtained are extremely diluted
and most biomarkers are at the low end of assay sensitivity. A
potential option to overcome this problem is to increase the
concentration of the samples, as was done with LTB4, with
lyophilization being one of the methods of choice [1,5,6]. Fur-
thermore, the relative contribution of the lower respiratory tract
versus alveoli in the final composition of the sample obtained
is unknown. Nevertheless, in mechanically ventilated patients
we minimize one of the main problems of this technique, which
is salivary contamination of the sample.
Conclusion
In summary, EBC is a novel technique that can be used to
monitor ventilated patients and to assess therapeutic interven-
tions. In the future, it may have an important role in monitoring
ALI patients because it is completely noninvasive and no
adverse effects have been described to date. In our small
series, inhaled salbutamol significantly increased the deaer-
ated EBC pH and showed a tendency to decrease nitrosative
species and the 8-isoPGF2α concentration in patients with
ALI.
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